메뉴 건너뛰기




Volumn 123, Issue 10, 2010, Pages 922-928

Outcomes in patients with rheumatoid arthritis and myocardial infarction

Author keywords

Congestive heart failure; Coronary artery bypass grafting; Mortality; Myocardial infarction; Percutaneous coronary intervention; Rheumatoid arthritis

Indexed keywords

AGED; ARTICLE; BLOOD CLOT LYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; COMPLICATION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; HEART FAILURE; MYOCARDIAL INFARCTION; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

EID: 77957779180     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.017     Document Type: Article
Times cited : (34)

References (15)
  • 2
    • 0037432305 scopus 로고    scopus 로고
    • Cardiovascular mortality and morbidity in women diagnosed with rheumatoid arthritis
    • D.H. Solomon, E.W. Karlson, and E.B. Rimm Cardiovascular mortality and morbidity in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303 1307
    • (2003) Circulation , vol.107 , pp. 1303-1307
    • Solomon, D.H.1    Karlson, E.W.2    Rimm, E.B.3
  • 3
    • 0036229685 scopus 로고    scopus 로고
    • Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
    • S. Van Doornum, G. McColl, and I.P. Wicks Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46 2002 862 873
    • (2002) Arthritis Rheum , vol.46 , pp. 862-873
    • Van Doornum, S.1    McColl, G.2    Wicks, I.P.3
  • 4
    • 0037471842 scopus 로고    scopus 로고
    • New evidence for vascular disease in patients with early rheumatoid arthritis
    • M.J. Kaplan, and W.J. McCune New evidence for vascular disease in patients with early rheumatoid arthritis Lancet 361 2003 1068 1069
    • (2003) Lancet , vol.361 , pp. 1068-1069
    • Kaplan, M.J.1    McCune, W.J.2
  • 5
    • 33749339372 scopus 로고    scopus 로고
    • Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
    • P. McGettigan, and D. Henry Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 JAMA 296 2006 1633 1644
    • (2006) JAMA , vol.296 , pp. 1633-1644
    • McGettigan, P.1    Henry, D.2
  • 6
    • 17144381293 scopus 로고    scopus 로고
    • Reversing myocardial microvascular disease in a patient with rheumatoid arthritis
    • K. Raza, M. Banks, and G.D. Kitas Reversing myocardial microvascular disease in a patient with rheumatoid arthritis J Rheumatol 32 2005 754 756
    • (2005) J Rheumatol , vol.32 , pp. 754-756
    • Raza, K.1    Banks, M.2    Kitas, G.D.3
  • 7
    • 51849095495 scopus 로고    scopus 로고
    • The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
    • J.M. Davis 3rd, V.L. Roger, and C.S. Crowson The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population Arthritis Rheum 58 2008 2603 2611
    • (2008) Arthritis Rheum , vol.58 , pp. 2603-2611
    • Davis III, J.M.1    Roger, V.L.2    Crowson, C.S.3
  • 8
    • 33745884118 scopus 로고    scopus 로고
    • Increased case fatality rates following a first myocardial event in patients with rheumatoid arthritis
    • S. Van Doornum, C. Brand, B. King, and V. Sundararajan Increased case fatality rates following a first myocardial event in patients with rheumatoid arthritis Arthritis Rheum 54 2006 2061 2068
    • (2006) Arthritis Rheum , vol.54 , pp. 2061-2068
    • Van Doornum, S.1    Brand, C.2    King, B.3    Sundararajan, V.4
  • 9
    • 47649116933 scopus 로고    scopus 로고
    • Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in unique dually coded database
    • IMECCHI Investigators L.D
    • H. Quan, B. Li, L.D. Saunders IMECCHI Investigators Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in unique dually coded database Health Serv Res 43 2008 1424 1441
    • (2008) Health Serv Res , vol.43 , pp. 1424-1441
    • Quan, H.1    Li, B.2    Saunders, L.D.3
  • 10
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
    • R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613
    • (1992) J Clin Epidemiol , vol.45 , pp. 613
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 11
  • 12
    • 58249112753 scopus 로고    scopus 로고
    • Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction
    • R.L. Rudominer, M.J. Roman, and R.B. Devereux Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction Arthritis Rheum 60 2009 22 29
    • (2009) Arthritis Rheum , vol.60 , pp. 22-29
    • Rudominer, R.L.1    Roman, M.J.2    Devereux, R.B.3
  • 13
    • 26844451781 scopus 로고    scopus 로고
    • How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    • C.S. Crowson, P.J. Nicola, and H.M. Kremers How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52 2005 3039 3044
    • (2005) Arthritis Rheum , vol.52 , pp. 3039-3044
    • Crowson, C.S.1    Nicola, P.J.2    Kremers, H.M.3
  • 14
    • 0038755661 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: RESULTS: of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
    • Anti-TNF Therapy Against Congestive Heart Failure Investigators K.H
    • E.S. Chung, M. Packer, K.H. Lo Anti-TNF Therapy Against Congestive Heart Failure Investigators Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: RESULTS: of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial Circulation 107 2003 3133 3140
    • (2003) Circulation , vol.107 , pp. 3133-3140
    • Chung, E.S.1    Packer, M.2    Lo, K.H.3
  • 15
    • 47849128962 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis
    • S. Setoguchi, S. Schneeweiss, and J. Avorn Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis Am Heart J 156 2008 336 341
    • (2008) Am Heart J , vol.156 , pp. 336-341
    • Setoguchi, S.1    Schneeweiss, S.2    Avorn, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.